(NYSE: PFE) today announced topline results from the Phase 3 MagnetisMM-32 study evaluating ELREXFIO ® (elranatamab) as monotherapy in adults with relapsed or refractory multiple myeloma (RRMM) who ...
Prostate-specific membrane antigen (PSMA)-targeted radiopharmaceutical therapy is safe and effective for patients with ...
From LED face masks to hair growth caps and full-body blankets, discover red light therapy gifts for every wellness lover, ...
In the study, pembrolizumab plus enfortumab vedotin as perioperative treatment demonstrated a statistically significant improvement in event-free survival (Efs), reducing the risk of Efs events by 47% ...
Msd announced today that the European Commission has approved pembrolizumab in combination with enfortumab vedotin, as neoadjuvant treatment and subsequently, after radical cystectomy, as adjuvant ...
Fear of late-stage cancer, sudden cardiovascular events, and aneurysms has made full-body scans a healthcare trend more ...
Red light therapy is popular for its potential benefits, but evidence to support its effectiveness is limited.What you can do ...
A tighter watch, ring, sleeve or shoe after cancer treatment may signal lymphedema. Learn the early signs, risk factors, study findings and treatment options.
Red light therapy involves applying low levels of red light to parts of the body. Red light, which has a longer wavelength and lower amount of energy than natural daylight, can travel deep into the ...
Glow-up or gimmick?
FDA authorized Ameluz plus red-light PDT for adult superficial BCC, marking the first FDA-approved PDT indication for a skin cancer and expanding beyond actinic keratosis. Treatment is delivered ...
Background Benign prostatic hyperplasia (BPH) is a highly prevalent cause of lower urinary tract symptoms (LUTS) in the aging male population. Photoselective vaporization of the prostate (PVP) and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results